Morning Overview on MSN
A genomic test let two-thirds of high-risk breast cancer patients safely skip chemotherapy
Thousands of women diagnosed with early-stage breast cancer who would once have been sent straight to chemotherapy can now ...
Federal health officials are quietly moving to overhaul the fine print on testosterone replacement therapy, a shift that ...
MarketBeat on MSN
Vertex Pharmaceuticals bets $10 billion on Crinetics to build endocrinology powerhouse
Key Points Interested in Vertex Pharmaceuticals Incorporated? Here are five stocks we like better. Vertex Pharmaceuticals agreed to buy Crinetics Pharmaceuticals for $85 per share in cash, valuing the ...
Current GLP-1 receptor agonist prescriptions were associated with modestly lower AUDIT-C scores in a large, diverse US cohort ...
A study of young women referred for PMOS finds high rates of liver steatosis, while commonly used screening tools miss most cases of liver fibrosis.
The American Cancer Society recently updated its colorectal cancer screening guideline for the first time since 2018 by ...
A good place to start is by asking them in return, “why do you ask?” This can help divert people who are just being nosy and ...
Two new tests, EndoSure and Endotest, could drastically reduce the years-long wait for endometriosis diagnoses for millions ...
Artificial intelligence can explain diseases and simplify medical information, but it cannot examine a patient or replace ...
Two new rapid tests, EndoSure and Endotest, can drastically reduce wait times for a diagnosis of endometriosis—from 9-years ...
Online “high cortisol” claims are everywhere. A doctor explains what it really means and what to do first if you’re worried.
Women with endometriosis show a distinct blood androgen profile that distinguishes them from women without the disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results